Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, BioXcel Therapeutics Inc (NASDAQ: BTAI) closed at $0.41 down -1.38% from its previous closing price of $0.41. In other words, the price has decreased by -$1.38 from its previous closing price. On the day, 2.11 million shares were traded. BTAI stock price reached its highest trading level at $0.52 during the session, while it also had its lowest trading level at $0.3454.
Ratios:
For a deeper understanding of BioXcel Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.87.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 21, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $9 previously.
On August 15, 2023, Mizuho Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $40 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 16 ’24 when O’Neill Vincent bought 165 shares for $0.35 per share.
Rodriguez Javier bought 430 shares of BTAI for $153 on Dec 16 ’24. On Dec 16 ’24, another insider, Yocca Frank, who serves as the Officer of the company, bought 430 shares for $0.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTAI now has a Market Capitalization of 19648790 and an Enterprise Value of 68555056. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.66. Its current Enterprise Value per Revenue stands at 28.529 whereas that against EBITDA is -0.657.
Stock Price History:
Over the past 52 weeks, BTAI has reached a high of $4.17, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is -26.32%, while the 200-Day Moving Average is calculated to be -69.90%.
Shares Statistics:
For the past three months, BTAI has traded an average of 623.54K shares per day and 856540 over the past ten days. A total of 42.46M shares are outstanding, with a floating share count of 40.05M. Insiders hold about 17.16% of the company’s shares, while institutions hold 6.57% stake in the company. Shares short for BTAI as of 1730332800 were 347081 with a Short Ratio of 1.44, compared to 1727654400 on 516384. Therefore, it implies a Short% of Shares Outstanding of 347081 and a Short% of Float of 1.09.
